In stock
Gemcitabine Jazeera 1gm/100ml Vial
In stock
Only 1 left
SKU
10331014210
Gemcitabine Jazeera 40 mg/ml is an antineoplastic agent used in chemotherapy regimens for various cancers like pancreatic, lung, breast, and ovarian cancer. Supplied as a lyophilisate for intravenous infusion, it works by inhibiting DNA synthesis in cancer cells. This prescription-only medicine must be administered by healthcare professionals.
For professional pharmaceutical information, please refer to reputable sources such as Nahdi Online, , and .
Experience professional pharmaceutical information regarding Gemcitabine Jazeera 40 mg/ml Lyophilisate For Solution For Infusion, a vital medication in oncology.
As detailed on reputable pharmaceutical platforms, this product is meticulously formulated to meet rigorous medical standards.
Product Overview:
Gemcitabine Jazeera is an antineoplastic agent, specifically a nucleoside metabolic inhibitor, used in various chemotherapy regimens.
It is supplied as a lyophilisate (powder) for solution for infusion, ensuring precise dosage and administration.
Benefits of Use:
This medication is a cornerstone in the treatment of several types of cancer, including:
How to Use:
Caution & Warnings:
Ingredients:
Product Details:
Experience professional pharmaceutical information regarding Gemcitabine Jazeera 40 mg/ml Lyophilisate For Solution For Infusion, a vital medication in oncology.
As detailed on reputable pharmaceutical platforms, this product is meticulously formulated to meet rigorous medical standards.
Product Overview:
Gemcitabine Jazeera is an antineoplastic agent, specifically a nucleoside metabolic inhibitor, used in various chemotherapy regimens.
It is supplied as a lyophilisate (powder) for solution for infusion, ensuring precise dosage and administration.
Benefits of Use:
This medication is a cornerstone in the treatment of several types of cancer, including:
- Pancreatic cancer
- Non-small cell lung cancer
- Breast cancer
- Ovarian cancer
How to Use:
- Gemcitabine Jazeera is administered intravenously (IV) as an infusion.
- Administration should only be performed by healthcare professionals experienced in the use of antineoplastic agents.
- The dosage and schedule of administration are highly individualized, determined by the patient's specific cancer type, stage, overall health, and response to treatment.
- The lyophilisate must be reconstituted with an appropriate diluent and then further diluted before intravenous infusion, strictly following package insert instructions.
Caution & Warnings:
- Severe myelosuppression (bone marrow suppression) leading to anemia, leukopenia, and thrombocytopenia is a dose-limiting toxicity. Complete blood counts should be monitored regularly.
- Hepatotoxicity and renal toxicity have been reported; liver and kidney function should be assessed periodically.
- Pulmonary toxicity, including interstitial pneumonitis, may occur. Patients should be monitored for respiratory symptoms.
- Flu-like symptoms (fever, headache, chills, myalgia, asthenia) are common and usually mild to moderate.
- Extravasation (leakage from the vein into surrounding tissue) can cause tissue damage. Proper infusion technique is crucial.
- Pregnancy and breastfeeding: Gemcitabine can cause fetal harm and is contraindicated during pregnancy. Women of childbearing potential should use effective contraception.
- Vaccinations: Live vaccines are not recommended during treatment with Gemcitabine.
- This medication requires careful handling and disposal in accordance with local guidelines for cytotoxic drugs.
Ingredients:
- Active Ingredient: Gemcitabine (as hydrochloride)
- Excipients: Contains necessary excipients for lyophilized product formulation.
Product Details:
- Form: Lyophilisate for solution for infusion (Powder for solution for infusion)
- Strength: 40 mg/ml (after reconstitution)
- Package Size: 25ml Vial
- Brand: Jazeera
- Manufacturer: Jazeera Pharmaceutical Industries
- Legal Status: Prescription Only Medicine (POM)
| Gtin | 712222985 |
|---|---|
| Recommended Sale Price | 234 |
| Is Wasfaty Product | No |
| Brand | Not Defined |
| Ingredient Name | GEMCITABINE |
| SFDA Reg. No | 712222985 |
| IBC | 712222985 |
| Drug Type | Prescription |
| Scientific Name | Gemcitabine |
| Strength | 40 mg/ml |
| Strength Unit | mg/ml |
| Form | Lyophilisate for solution for infusion |
| Admin Route | Intravenous |
| Size | 25 |
| Size Unit | ml |
| Package Types | Vial |
| Package Size | 1 Vial of 25ml |
| Refrigerator Storage | No |
Products you might like
